Aygen, B. et al. 2018. Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report. Turkish Journal of Gastroenterology. 29, 3 (Jan. 2018), 259–269. DOI:https://doi.org/10.5152/tjg.2018.18263.